|
Preface |
5 |
|
|
Contents |
7 |
|
|
Contributors |
9 |
|
|
Part I: Biotechnological Production of Selected Natural Products |
12 |
|
|
1: Vanilla: The Most Popular Flavour |
13 |
|
|
1.1 Introduction |
13 |
|
|
1.2 Vanilla Orchids, Vanilla Flowers and the Pod |
14 |
|
|
1.3 When the Green Becomes Black – Vanilla Pod Curing |
17 |
|
|
1.4 Vanillin Is the Key Flavour Compound of the Complex Vanilla Extract |
18 |
|
|
1.5 How Does the Vanilla Plant Form Vanillin? |
20 |
|
|
1.6 Flavour Synthesis by Brewing – Bioengineering of Vanillin Biosynthesis |
21 |
|
|
1.7 Biotechnology-Based Production of Vanillin from Eugenol, Iso-Eugenol, Ferulic Acid and Glucose |
24 |
|
|
1.8 Future Perspectives and Final Remarks |
29 |
|
|
References |
30 |
|
|
2: Rosmarinic Acid and Related Metabolites |
35 |
|
|
2.1 Occurrence and Structures of Rosmarinic Acid and Related Metabolites |
36 |
|
|
2.2 Biosynthetic Pathway of Rosmarinic Acid |
42 |
|
|
2.3 Production of RA in Untransformed Aseptic In Vitro Cultures |
44 |
|
|
2.3.1 Species from the Family Lamiaceae |
44 |
|
|
2.3.2 Species of the Family Boraginaceae |
50 |
|
|
2.3.3 Non-vascular Plant Species |
52 |
|
|
2.4 Production of Rosmarinic Acid in Hairy Roots |
52 |
|
|
2.4.1 Hairy Roots of Lamiaceae Species |
52 |
|
|
2.4.2 Hairy Roots of Boraginaceae Species |
57 |
|
|
2.5 Production of Rosmarinic Acid and Related Caffeic Acid Esters in Microorganisms |
58 |
|
|
2.6 In Vitro Formation of Non-natural Hydroxycinnamic Acid Esters and Amides by “Rosmarinic Acid Synthase” |
60 |
|
|
2.7 Conclusion and Outlook |
61 |
|
|
References |
61 |
|
|
3: Bioproduction of Resveratrol |
71 |
|
|
3.1 Introduction |
71 |
|
|
3.2 Biosynthesis of Resveratrol and Its Analogs |
72 |
|
|
3.3 Bioproduction of Resveratrol in Microorganisms |
73 |
|
|
3.3.1 Yeast |
74 |
|
|
3.3.2 E. coli |
78 |
|
|
3.3.3 Other Bacteria |
79 |
|
|
3.4 Bioproduction of Resveratrol Analogs and Derivatives |
80 |
|
|
3.5 Strategies in Metabolic Engineering of Resveratrol Production |
81 |
|
|
3.5.1 Pathway Engineering to Increase Precursor Supply |
82 |
|
|
3.5.2 Protein Engineering |
83 |
|
|
3.6 Conclusion and Perspective |
84 |
|
|
References |
85 |
|
|
4: Anthocyanin Production in Engineered Microorganisms |
90 |
|
|
4.1 Anthocyanins and Their Industrial Applications |
91 |
|
|
4.1.1 Pharmaceutical Applications |
91 |
|
|
4.1.2 Food Colorants |
92 |
|
|
4.1.3 Cosmetic Industry |
92 |
|
|
4.1.4 Other Fields |
93 |
|
|
4.2 Plant-Based Anthocyanin Production |
93 |
|
|
4.2.1 Extraction from Plants |
94 |
|
|
4.2.2 Anthocyanin Production from Suspension Cell Culture |
94 |
|
|
4.3 Anthocyanin Production in Microorganisms |
96 |
|
|
4.3.1 Engineering of Pathway Enzymes |
97 |
|
|
4.3.2 Supply of Cofactors and Cosubstrates |
99 |
|
|
4.3.3 Engineering Anthocyanin Secretion |
100 |
|
|
4.3.4 Optimization of the Production Process |
100 |
|
|
4.4 Conclusions and Future Perspectives |
101 |
|
|
References |
102 |
|
|
5: Microbial Synthesis of Plant Alkaloids |
107 |
|
|
5.1 Introduction |
109 |
|
|
5.2 Reconstitution of MIA Biosynthetic Pathways |
114 |
|
|
5.2.1 Precursor Pathways |
115 |
|
|
5.2.2 Strictosidine Formation |
116 |
|
|
5.2.3 Downstream Derivatization |
117 |
|
|
5.3 Reconstitution of BIA Biosynthetic Pathways |
118 |
|
|
5.3.1 Upstream BIA Pathways |
118 |
|
|
5.3.2 Microbial Production of Morphinan Alkaloids |
121 |
|
|
5.3.3 Microbial Production of Protoberberine, Benzophenanthridine, and Phthalideisoquinoline Alkaloids |
122 |
|
|
5.3.3.1 Synthesis of Dihydrosanguinarine and Sanguinarine in Yeast |
122 |
|
|
5.3.3.2 Noscapine Synthesis in Yeast |
123 |
|
|
5.4 Microbial Engineering Challenges |
124 |
|
|
5.4.1 Functional Expression of Cytochromes P450 (CYPs) |
124 |
|
|
5.4.2 Taming Enzyme Promiscuity |
125 |
|
|
5.4.3 Limiting Efflux of Intermediates |
127 |
|
|
5.5 Optimization Strategies |
127 |
|
|
5.5.1 Genetic and Pathway Engineering Techniques |
127 |
|
|
5.5.1.1 Building Combinatorial Enzyme Libraries |
128 |
|
|
5.5.1.2 Pathway Assembly |
128 |
|
|
5.5.1.3 Tuning Gene Expression |
129 |
|
|
5.5.2 Cultivation Methods |
130 |
|
|
5.6 Conclusions and Future Directions |
131 |
|
|
References |
132 |
|
|
6: Caffeine |
139 |
|
|
6.1 Introduction |
139 |
|
|
6.2 Distribution of Caffeine in Plants |
139 |
|
|
6.3 Biosynthesis of Caffeine from Xanthosine |
141 |
|
|
6.4 The Caffeine Synthase Gene Family in Plants |
145 |
|
|
6.5 Biotechnological Production of Caffeine by Genetic Engineering |
148 |
|
|
References |
148 |
|
|
7: Taxol® Biosynthesis and Production: From Forests to Fermenters |
152 |
|
|
7.1 Introduction |
152 |
|
|
7.2 The Biosynthesis of Taxol |
155 |
|
|
7.3 Taxol Production by Endophytes |
161 |
|
|
7.4 Taxol Production by Plant Cell Cultures |
165 |
|
|
7.5 Microbial Biotechnology for the Production of Taxol |
176 |
|
|
7.6 Concluding Remarks |
179 |
|
|
References |
180 |
|
|
Part II: Technologies for Metabolic, Enzyme and Process Engineering |
193 |
|
|
8: Commercial-Scale Tissue Culture for the Production of Plant Natural Products: Successes, Failures and Outlook |
194 |
|
|
8.1 Introduction |
194 |
|
|
8.2 Commercial Products from Plant Tissue Culture |
197 |
|
|
8.3 Considerations for Commercial Targets |
201 |
|
|
8.4 Future Opportunities |
217 |
|
|
References |
219 |
|
|
9: Tailoring Natural Products with Glycosyltransferases |
224 |
|
|
9.1 Introduction |
225 |
|
|
9.2 The Significance of Glycosylation in Plants |
227 |
|
|
9.2.1 Glycosylation Increases Solubility |
227 |
|
|
9.2.2 Glycosylation Increases Stability |
227 |
|
|
9.2.3 Glycosylation Controls Sequestration/Compartmentalization |
228 |
|
|
9.2.4 Glycosylation Affects Bioactivity and -Availability |
229 |
|
|
9.2.5 Glycosylation Reduces Toxicity |
230 |
|
|
9.2.6 Glycosylation Affects Perception |
231 |
|
|
9.3 Glucoside/Glucose Ester Synthesis |
231 |
|
|
9.4 Family 1 Plant Glycosyltransferases |
233 |
|
|
9.5 Substrates of Family 1 Plant Glycosyltransferases |
234 |
|
|
9.5.1 Secondary Metabolites |
234 |
|
|
9.5.1.1 Phenylpropanoids |
235 |
|
|
9.5.1.2 Flavonoids, Anthocyanins |
236 |
|
|
9.5.1.3 Dihydrochalcones, Acylphloroglucinol, Stilbenes, Curcumin |
236 |
|
|
9.5.1.4 Terpenoids |
238 |
|
|
9.5.2 Plant Hormones |
239 |
|
|
9.5.3 Miscellaneous Substrates (Alkaloids, Benzoxazinoids, Furanones, and Xenobiotics) |
239 |
|
|
9.6 Glucoside Production by Whole Cell Biocatalysts |
240 |
|
|
9.6.1 Production System |
240 |
|
|
9.6.2 Types of Whole-Cell Biocatalysts |
247 |
|
|
9.6.3 Process Optimization |
247 |
|
|
9.6.3.1 Vector Conveyed Process Optimization |
248 |
|
|
9.6.3.2 UGT Optimization |
248 |
|
|
9.6.3.3 Host Genome Optimization – Metabolic Engineering |
249 |
|
|
9.7 Recent Applications of Glycosyltransferases for Production of Small Molecule Glycosides |
252 |
|
|
9.7.1 Glycosyltransferases and Glycosylation in Product for Consumer Consumption |
252 |
|
|
9.7.2 Glycorandomization |
254 |
|
|
9.7.3 Glycosyltransferases and Their Role in Cancer Therapies |
254 |
|
|
9.8 Conclusions and Future Prospects |
255 |
|
|
References |
256 |
|
|
Part III: Analytical and Legal Aspects |
269 |
|
|
10: Authenticity Control of Natural Products by Stable Isotope Ratio Analysis |
270 |
|
|
10.1 Introduction |
270 |
|
|
10.2 Isotope Ratio Mass Spectrometry – IRMS |
272 |
|
|
10.2.1 Notations in IRMS |
272 |
|
|
10.2.2 Elemental Analyzer-IRMS (EA-IRMS) and Gaschromatography-IRMS (GC-IRMS) |
273 |
|
|
10.2.3 Liquid Chromatography-IRMS (LC-IRMS) |
275 |
|
|
10.2.4 Site-Specific Natural Isotope Fractionation-Nuclear Magnetic Resonance Spectroscopy (SNIF-NMR) |
275 |
|
|
10.3 Practical Applications of Stable Isotope Analysis on Miscellaneous Natural Products |
276 |
|
|
10.3.1 Phenylpropanoids (Vanillin) |
276 |
|
|
10.3.2 Terpenes (Monoterpenes and Tetraterpenes) |
278 |
|
|
10.3.3 Polyphenols (Resveratrol) |
279 |
|
|
10.3.4 Alkaloids (Caffeine) |
280 |
|
|
10.4 Conclusions |
280 |
|
|
References |
280 |
|
|
11: Natural or Synthetic? The Legal Framework in the EU for the Production of Natural Flavouring Ingredients |
283 |
|
|
11.1 Introduction |
283 |
|
|
11.2 General Conditions |
284 |
|
|
11.3 Scope of the Regulation |
284 |
|
|
11.4 Definitions |
285 |
|
|
11.4.1 Definitions of Flavourings in General |
285 |
|
|
11.4.2 Definition of Natural Flavouring Substance |
286 |
|
|
11.4.3 Definitions of Flavouring Preparations |
290 |
|
|
11.5 Processes for the Production of Natural Flavouring Ingredients |
294 |
|
|
11.5.1 EFFA Considerations on the Permitted Order of the Various Processes |
294 |
|
|
11.5.2 Biotechnology for the Production of Natural Flavouring Ingredients |
295 |
|
|
11.5.3 Further Considerations on the Production of Natural Flavouring Substances and Flavouring Preparations According to the EFFA Guidance Document |
296 |
|
|
11.6 Analytical Methods to Assess Authenticity |
297 |
|
|
11.7 Labelling of Flavourings (B2B) |
298 |
|
|
11.7.1 General Labelling Requirements |
298 |
|
|
11.7.2 Labelling of Natural Flavourings |
299 |
|
|
11.7.3 Considerations on Different Interpretations of the 95/5-Rule (Art. 16(4)) |
302 |
|
|
11.8 Safety Evaluation of Flavourings and Their Inclusion in the EU Union List |
303 |
|
|
References |
306 |
|
|
Index |
308 |
|